Log in

OTCMKTS:MRMD - Marimed Stock Price, Forecast & News

$0.59
+0.05 (+9.26 %)
(As of 12/8/2019 04:01 AM ET)
Today's Range
$0.53
Now: $0.59
$0.60
50-Day Range
$0.54
MA: $0.84
$1.05
52-Week Range
$0.51
Now: $0.59
$5.33
Volume373,556 shs
Average Volume348,068 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
MariMed Inc. provides consulting services for the design, development, operation, funding, and optimization of medical cannabis cultivation, production, and dispensary facilities. The company also develops and manages facilities for the cultivation, production, and dispensing of legal cannabis and cannabis-infused products under the Kalm Fusion brand name. In addition, it offers legal, accounting, human resources, and other corporate and administrative services. As of December 31, 2017, it developed and managed six operating cannabis facilities for clients in Delaware, Illinois, Nevada, and Maryland. MariMed Inc. was incorporated in 2011 and is based in Newton, Massachusetts.

Industry, Sector and Symbol

Industry Packaged Software
Sub-IndustryN/A
SectorTechnology Services
Current SymbolOTCMKTS:MRMD
CUSIPN/A
CIKN/A
Phone(844) 244-0200

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees12
Next Earnings DateN/A
OptionableNot Optionable

Receive MRMD News and Ratings via Email

Sign-up to receive the latest news and ratings for MRMD and its competitors with MarketBeat's FREE daily newsletter.


Marimed (OTCMKTS:MRMD) Frequently Asked Questions

What is Marimed's stock symbol?

Marimed trades on the OTCMKTS under the ticker symbol "MRMD."

How were Marimed's earnings last quarter?

Marimed Inc (OTCMKTS:MRMD) released its quarterly earnings data on Monday, August, 12th. The company reported $0.02 EPS for the quarter. The firm earned $25.67 million during the quarter. View Marimed's Earnings History.

What guidance has Marimed issued on next quarter's earnings?

Marimed updated its third quarter 2019 IntraDay earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$11.22-11.22 million.

Has Marimed been receiving favorable news coverage?

Media coverage about MRMD stock has been trending somewhat positive this week, according to InfoTrie. The research firm identifies positive and negative press coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Marimed earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Marimed.

Who are some of Marimed's key competitors?

Some companies that are related to Marimed include Enghouse Systems (EGHSF), Exxe Group (AXXA), Sylogist (SYZLF), TECSYS (TCYSF) and View Systems (VSYM).

What other stocks do shareholders of Marimed own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marimed investors own include Canopy Growth (CGC), Cronos Group (CRON), Aurora Cannabis (ACB), Medmen Enterprises (MMNFF), Aphria (APHA), Charlotte's Web (CWBHF), Innovative Industrial Properties (IIPR), OrganiGram (OGI), Tilray (TLRY) and CV Sciences (CVSI).

Who are Marimed's key executives?

Marimed's management team includes the folowing people:
  • Mr. Robert N. Fireman, Pres, CEO & Director (Age 70)
  • Mr. Jon R. Levine, CFO, Treasurer, Sec. & Director (Age 54)
  • Mr. Tim Shaw, Chief Operating Officer
  • Ms. Sara Gullickson, VP of Marketing
  • Mr. Ryan Crandall, VP of Product & Sales

How do I buy shares of Marimed?

Shares of MRMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Marimed's stock price today?

One share of MRMD stock can currently be purchased for approximately $0.59.

What is Marimed's official website?

The official website for Marimed is http://marimedadvisors.com/.

How can I contact Marimed?

The company can be reached via phone at (844) 244-0200.


MarketBeat Community Rating for Marimed (OTCMKTS MRMD)

Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  94 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  124
MarketBeat's community ratings are surveys of what our community members think about Marimed and other stocks. Vote "Outperform" if you believe MRMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MRMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Featured Article: What is the Beige Book?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel